Mathematical modelling of the interactions between antibodies and virus

2008 Conference on Human System Interaction, HSI 2008

Volumn , Issue , 2008, Pages 365-368

  Kolev, Mikhail K ^a  

^a UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

Author keywords

Antibodies; Cytopathic virus; Humoral immunity; Integro differential equations; Kinetic models

Indexed keywords

DIFFERENCE EQUATIONS; DIFFERENTIAL EQUATIONS; DIFFERENTIATION (CALCULUS); FLOW INTERACTIONS; FRUITS; MATHEMATICAL MODELS; PARTIAL DIFFERENTIAL EQUATIONS; VIRUSES;

ANTIBODIES; CYTOPATHIC VIRUS; CYTOTOXIC T LYMPHOCYTES; HUMAN-SYSTEM INTERACTION; HUMORAL IMMUNITY; IMMUNE SYSTEMS; INTEGRO-DIFFERENTIAL BILINEAR EQUATIONS; INTEGRO-DIFFERENTIAL EQUATIONS; KINETIC MODELS; MATHEMATICAL MODELLING; VIRAL INFECTIONS;

ORDINARY DIFFERENTIAL EQUATIONS;

EID: 51849089657     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/HSI.2008.4581465     Document Type: Conference Paper

References (30)

1. J. Kuby, Immunology. New York: W.H.Freeman, 1997.
2. P.M. Lydyard, A. Whelan and M.W. Fanger, Instant Notes in Immunology. Oxford: BIOS Scientific Publishers Ltd., 2000.
3. B. Asquith and Ch. R. M. Bangham, "An introduction to lymphocyte and viral dynamics: the power and limitations of mathematical analysis," Proc. R. Soc. Lond. B, vol. 270, pp. 1651-1657, 2003
4. N. Bellomo and L. Preziosi, "Modelling and Mathematical Problems Related to Tumor Evolution and Its Interaction with the Immune System," Math. Comput. Modelling, vol. 32, pp. 413-452, 2000.
5. H. M. Byrne, M.R. Owen, T. Alarcon, J. Murphy and P.K. Maini, "Modelling the response of vascular tumours to chemotherapy: A multiscale approach," Math. Models Methods Appl. Sci., vol. 16 (7b), pp. 1219-1242, 2006.
6. D Wodarz, Killer Cell Dynamics. New York, Berlin: Springer, 2006.
7. N. Bellomo and A. Bellouquid, "On the onset of nonlinearity for diffusion models of binary mixtures of biological materials by asymptotic analysis," Internat. J. Nonlinear Mech., vol. 41(2), pp. 281-293, 2006.
8. P.L. Lollini, S. Motta and P. Pappalardo, "Modeling tumor immunology," Math. Models Methods Appl. Sci., vol. 16 (7b), pp. 1091-1125, 2006.
9. A. d'Onofrio, "Tumor-immune system interaction and immunotherapy: Modelling the tumor-stimulated proliferation of effectors," Math. Models Methods Appl. Sci., vol. 16 (8), pp. 1375-1402, 2006.
10. N. Bellomo and G. Forni, "Dynamics of tumor interaction with the host immune system," Math. Comput. Modelling, vol. 20, pp. 107-122, 1994.
11. N. Bellomo, E. De Angelis and L. Preziosi, "Multiscale modeling and mathematical problems related to tumor evolution and medical therapy," J. Theor. Med., vol. 5, pp. 111-136, 2003.
12. N. Bellomo, A. Bellouquid and M. Delitala, "Mathematical topics of the modelling complex multicellular systems and tumor immune cells competition," Math. Models Methods Appl. Sci., vol. 14, pp. 1683-1733, 2004.
13. A. Bellouquid and M. Delitala, "Mathematical methods and tools of kinetic theory towards modelling complex biological systems," Math. Models Methods Appl. Sci., vol. 15 (11), pp. 1639-1666, 2005.
14. E. De Angelis and M. Delitala, "Modelling complex systems in applied sciences; methods and tools of the mathematical kinetic theory for active particles," Math.Comput. Modelling, vol. 43 (11-12), pp. 1310-1328, 2006.
15. N. Bellomo and G. Forni, "Looking for new paradigms towards a biological-mathematical theory of complex multicellular systems," Math. Models Methods Appl. Sci., vol. 16 (7), pp. 1001-1029, 2006.
16. N. Bellomo and A. Bellouquid, "On the mathematical kinetic therapy of active particles with discrete states - The derivation of macroscopic equations", Math. Comput. Modelling, vol. 44, pp. 397-404, 2006.
17. S. De Lillo, M.C. Salvatori and N. Bellomo, "Mathematical tools of the kinetic theory of active particles with some reasoning on the modelling progression and heterogeneity," Math. Comput. Modelling, vol. 45 (5-6), pp. 564-578, 2007.
18. Z. Jackiewicz, C.L. Jorcyk, M. Kolev and B. Zubik-Kowal, "Correlation between animal and mathematical models for prostate cancer progression," submitted for publication.
19. F. Calabi and M.S. Neuberger, Editors, Genetics of Immunoglobulin, Elsevier, 1987.
20. I.M. Roitt, Essential Immunology, Oxford: Blackwell Scientific, 1991.
21. W.E. Paul, Editor, Fundamental Immunology, New York: Raven Press, 1984.
22. M.R. Sandbulte, G.S. Jimenez, A.C.M. Boon, L.R. Smith, J.J. Treanor, R.J. Webby, "Cross-Reactive Neuraminidase Antibodies Afford Partial Protection against H5N1 in Mice and Are Present in Unexposed Humans", PLoS Med, 4(2): e59 doi: 10.1371/journal.pmed.0040059, 2007.
23. C.P. Simmons, N.L. Bernasconi, A.L. Jr. Suguitan, K. Mills, J.M. Ward, N.V.V. Chau, T.T. Hien, F. Sallusto, D.Q. Ha, J. Farrar, M.D. de Jong, A. Lanzavecchia, K. Subbarao, "Prophylactic and Therapeutic Efficacy of Human Monoclonal Antibodies against H5N1 Influenca", PLoS Med, 4(5): e178 doi: 10.1371/journal.pmed.0040178, 2007.
24. M. Kolev, "Mathematical Modelling of the Competition between Tumors and Immune System Considering the Role of the Antibodies," Math. Comput. Modelling, vol. 37, pp. 1143-1152, 2003.
25. D. Wodarz, R. May and M. Nowak, "The role of antigen-independent persistence of memory cytotoxic T lymphocytes," Intern.Immun., vol. 12 (4), pp. 467-477, 2000.
26. L. Arlotti, A. Gamba and M. Lachowicz, "A kinetic model of tumor-immune system cellular interactions," J. Theor. Medicine, vol. 4 (1), pp. 39-50, 2002.
27. M. Kolev, E. Kozlowska and M. Lachowicz, "A mathematical model for single cell cancer-immune system dynamics," Math. Comput. Modelling, vol. 41 (8), pp. 1083-1095, 2005.
28. M.W. Shampine and M.W. Reichelt, "The Matlab ODE suite," SIAM J. Sci. Comput., vol. 18, pp. 1-22, 1997.
29. D. Kagi, P. Seiler, J. Pavlovic, B. Ledermann, K. Burki, R.M. Zinkernagel and H. Hengartner, "The roles of perforin-dependent and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses," Eur. J. Immunol., vol. 25, p.3256, 1995.
30. D. Kagi and H. Hengartner, "Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses," Curr.Opin. Immunol., vol. 8, p.472, 1996.